Latest
Hot
Unlock Pro Investors’ Money-Making Secrets
Join Futubull Community! Now Connect Directly with Top Investors & Public Company Executives
Will you subscribe for HARBOUR's listing in Hong Kong?
和鉑醫藥-B於11月30日開啟招股，美股發售價11.7-12.92港元，每手1000股，入場費13050.2港元，12月3日截止認購，預計將於12月10日上市。
高瓴、貝萊德投資的生物醫藥B類股，你會參與認購嗎？
和鉑醫藥-B於11月30日開啟招股，美股發售價11.7-12.92港元，每手1000股，入場費13050.2港元，12月3日截止認購，預計將於12月10日上市。
高瓴、貝萊德投資的生物醫藥B類股，你會參與認購嗎？
高瓴、貝萊德投資的生物醫藥B類股，你會參與認購嗎？
Views
257K
Posts
44
Follow
Join topic
Related Stocks
No Data
Professional Views
Similar Topics
More
- 2026 IPO bonanza! Over 90% of new stocks rose on their debut!52.7M Views · 14K Posts
- Xuanzhu Biotech opened more than 150% higher on its first day. Would you still consider investing?1.1M Views · 333 Posts
- Is the Gray Market Surge Just the Beginning? GenFleet Therapeutics Soars Over 140% on Debut!1.3M Views · 510 Posts
- Zijin Mining and XPL Soar on Debut! Is It Too Late to Buy In?9.3M Views · 1418 Posts
- Dahon Tech's stock opened 36% higher on its first day. Should we take profits or double down?1.3M Views · 199 Posts